nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A review of retroperitoneal liposarcoma genomics
|
Tyler, Robert |
|
|
86 |
C |
p. |
artikel |
2 |
Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook
|
Garcia, Josep |
|
|
86 |
C |
p. |
artikel |
3 |
Broadening the therapeutic horizon of advanced biliary tract cancer through molecular characterisation
|
Athauda, Avani |
|
|
86 |
C |
p. |
artikel |
4 |
Editorial Board
|
|
|
|
86 |
C |
p. |
artikel |
5 |
Evolving role of regorafenib for the treatment of advanced cancers
|
Grothey, Axel |
|
|
86 |
C |
p. |
artikel |
6 |
Imaging and clinical correlates with regorafenib in metastatic colorectal cancer
|
Khan, Khurum |
|
|
86 |
C |
p. |
artikel |
7 |
Immunotherapy for pancreatic cancer: A 2020 update
|
Schizas, Dimitrios |
|
|
86 |
C |
p. |
artikel |
8 |
MSI as a predictive factor for treatment outcome of gastroesophageal adenocarcinoma
|
van Velzen, M.J.M. |
|
|
86 |
C |
p. |
artikel |
9 |
Parathyroid cancer: An update
|
Rodrigo, Juan P. |
|
|
86 |
C |
p. |
artikel |
10 |
Resistance to anti-epidermal growth factor receptor in metastatic colorectal cancer: What does still need to be addressed?
|
Martini, Giulia |
|
|
86 |
C |
p. |
artikel |
11 |
Review of precision cancer medicine: Evolution of the treatment paradigm
|
Tsimberidou, Apostolia M. |
|
|
86 |
C |
p. |
artikel |
12 |
Targeting complex, adaptive responses in melanoma therapy
|
Cheng, Phil |
|
|
86 |
C |
p. |
artikel |
13 |
Targeting the PI3K pathway and DNA damage response as a therapeutic strategy in ovarian cancer
|
Huang, Tzu-Ting |
|
|
86 |
C |
p. |
artikel |
14 |
The force of HER2 – A druggable target in NSCLC?
|
Jebbink, M. |
|
|
86 |
C |
p. |
artikel |
15 |
The future of bladder cancer therapy: Optimizing the inhibition of the fibroblast growth factor receptor
|
Morales-Barrera, Rafael |
|
|
86 |
C |
p. |
artikel |
16 |
The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target
|
Gambardella, V. |
|
|
86 |
C |
p. |
artikel |
17 |
The safety and efficacy of immune checkpoint inhibitors in patients with advanced cancers and pre-existing chronic viral infections (Hepatitis B/C, HIV): A review of the available evidence
|
Tapia Rico, G. |
|
|
86 |
C |
p. |
artikel |
18 |
Thymic epithelial tumors: From biology to treatment
|
Conforti, Fabio |
|
|
86 |
C |
p. |
artikel |